Tags

Type your tag names separated by a space and hit enter

Dolutegravir/lamivudine (Dovato)--a two-drug complete regimen for HIV-1 infection.
Med Lett Drugs Ther 2019; 61(1579):134-136ML

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

31581158

Citation

"Dolutegravir/lamivudine (Dovato)--a Two-drug Complete Regimen for HIV-1 Infection." The Medical Letter On Drugs and Therapeutics, vol. 61, no. 1579, 2019, pp. 134-136.
Dolutegravir/lamivudine (Dovato)--a two-drug complete regimen for HIV-1 infection. Med Lett Drugs Ther. 2019;61(1579):134-136.
(2019). Dolutegravir/lamivudine (Dovato)--a two-drug complete regimen for HIV-1 infection. The Medical Letter On Drugs and Therapeutics, 61(1579), pp. 134-136.
Dolutegravir/lamivudine (Dovato)--a Two-drug Complete Regimen for HIV-1 Infection. Med Lett Drugs Ther. 2019 Aug 26;61(1579):134-136. PubMed PMID: 31581158.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dolutegravir/lamivudine (Dovato)--a two-drug complete regimen for HIV-1 infection. PY - 2019/10/4/entrez PY - 2019/10/4/pubmed PY - 2019/11/14/medline KW - 3TC KW - Dovato KW - Epivir KW - HIV KW - Juluca KW - NNRTIs KW - Tivicay KW - abacavir KW - adverse effects KW - antiretrovirals KW - dolutegravir KW - dosage KW - drug interactions KW - efficacy KW - emtricitabine/tenofovir KW - lamivudine KW - pregnancy KW - rilpivirine KW - safety KW - tenofovir KW - tenofovir alafenamide SP - 134 EP - 136 JF - The Medical letter on drugs and therapeutics JO - Med Lett Drugs Ther VL - 61 IS - 1579 SN - 1523-2859 UR - https://www.unboundmedicine.com/medline/citation/31581158/Dolutegravir/lamivudine_(Dovato)--a_two-drug_complete_regimen_for_HIV-1_infection L2 - http://www.medicalletter.org/scripts/articlefind.cgi?issue=1579&page=134 DB - PRIME DP - Unbound Medicine ER -